Benchmark Research - Fort Worth

Fort Worth, Texas 76135

0 studies enrolling now · 8 studies all time

What they study most

Chronic Noncancer Pain, Influenza, SARS-CoV-2, Smoking, Zika Virus

Studies at this site

• A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas — Completed
• A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 — Completed
• Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok — Completed
• Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age — Completed
• Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older — Completed
• Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain — Completed
• Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age — Completed
• Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation — Completed